Ampicillin-resistant Escherichia coli enhances neutrophil extracellular trap release to induce liver metastasis of colorectal cancer_CUT&Tag
The emergence of research on intratumoral bacteria and its correlation with the post-metastatic niche has garnered interest, yet the impact on liver metastasis of colorectal cancer through neutrophils remains unexplored. Our study confirmed the enrichment of ampicillin-resistant Escherichia coli (Am-R-E.coli) in the niche post-liver metastasis, revealing that Am-R-E.coli bolstered the release of neutrophil extracellular trap (NETs). This activation induced heightened expression of S100A8/9-STAT3 in colorectal cancer cells, resulting in increased invasion, migration, and proliferation. However, the precise mechanism remains unclear. Our recent findings indicated that RIPK2 enhanced the expression of ATF3/RelB in neutrophils and S100A8/9 interacted with STAT3 in tumor cells. As a result, we hypothesized that ATF3/RelB binds to the promoters of specific genes in neutrophils, leading to NETs release. Additionally, in tumor cells, S100A8/9 binding to STAT3 facilitated the proximity of promoters and enhancers of downstream genes through the common motifs. This study offered a theoretical foundation supporting the assertion that "intratumoral bacteria facilitate the liver metastasis of colorectal cancer," and contributed to the advancement of immunotherapy medications designed to target Am-R-E.coli and RIPK2.